1. Home
  2. SNGX vs OLB Comparison

SNGX vs OLB Comparison

Compare SNGX & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.39

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.37

Market Cap

6.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
OLB
Founded
1987
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.6M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
SNGX
OLB
Price
$0.39
$0.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
903.1K
146.4K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
71.48
EPS
N/A
N/A
Revenue
$119,371.00
$8,676,907.00
Revenue This Year
N/A
$12.19
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.31
52 Week High
$6.23
$1.86

Technical Indicators

Market Signals
Indicator
SNGX
OLB
Relative Strength Index (RSI) 39.82 31.60
Support Level $0.37 $0.31
Resistance Level $0.41 $0.59
Average True Range (ATR) 0.02 0.03
MACD 0.01 -0.00
Stochastic Oscillator 21.25 5.78

Price Performance

Historical Comparison
SNGX
OLB

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: